A model of H19 knockout mice suggested that H19 promoted tumor progression and tumor cell proliferation after treatment with the carcinogen diethylnitrosamine (DEN), while administration of insulin-like growth factor 2 (IGF2) had no effect. This evidence concerns the gene H19 and neoplasm.